Vol. 21/No. 16 | OncologyLive

Experts Decode the Future of Biosimilars in Breast Cancer

August 25, 2020


During a recent OncLive Peer Exchange®, a panel of hematology-oncology experts discussed some of the challenges surrounding the integration of biosimilars in clinical practice using the breast cancer landscape.

A View From the Frontlines: How a Hospital System Coped With a COVID-19 Peak

August 19, 2020

Partner Perspective

Early in the pandemic, the Montefiore hospital leadership had the forethought and insight to create a reliable and robust outcomes data collection system on all patients with a diagnosis of COVID-19 being seen and treated within the system.

Tazemetostat Expands Follicular Lymphoma Tool Kit

August 18, 2020

The approval of tazemetostat has expanded the portfolio of treatment options for relapsed/refractory follicular lymphoma, a disease for which new agents are needed because patients do not uniformly derive benefit from available therapies.